Guan Chao Holdings Limited
HHKEX:18723.88
HKD
-0.18
(-4.44%)
ISIN
KYG4183A1195
CUSIP
G4183A119
Return %
Stock
S&P 500
1Y
-49.61
14.20
3Y
49.89
81.12
5Y
-44.48
68.34
Capital Structure
SGD
•
in mil. unless spec.Working Capital
SGD
•
in mil. unless spec.Growth Rates
SGD
•
in mil. unless spec.Semi-annual Revenue
SGD
•
in mil. unless spec.Semi-annual Earnings Per Share
SGD
•
in mil. unless spec.Semi-annual Dividends Per Share
SGD
•
in mil. unless spec.Company Description
- CEO
- Shuay Tarng Tan
- Full Time Employees
- 230
- Sector
- Retail trade
- Industry
- Specialty stores
- Address
- #01–02, Leng Kee Autopoint Singapore CE Singapore 159096
- IPO Date
- Feb 28, 2019
- Website
- guanchaoholdingsltd.com
- Similar Companies
- Business
- Guan Chao Holdings Limited (1872.HK) is a Singapore-based investment holding company principally engaged in the sale of parallel-import new motor vehicles and pre-owned motor vehicles in Singapore. The Group offers a comprehensive range of multi-brand vehicles encompassing Japanese marques such as Toyota, Honda, Nissan and Mazda, as well as Continental brands including Mercedes-Benz, BMW, Audi and Porsche; it provides ancillary services comprising motor vehicle financing and insurance agency services, motor vehicle leasing and rental, and sales of spare parts and motor vehicle accessories. Subsidiaries include Solution Lion Limited, Vincar Pte. Ltd., Vincar Leasing and Rental Pte. Ltd. and Vincar EV Pte. Ltd., with operations centered in Singapore through an integrated showroom and service center at 24 Leng Kee Road, Leng Kee Autopoint. Founded in 1989 and headquartered at 24 Leng Kee Road, #01-02, Leng Kee Autopoint, Singapore 159096, the Group targets individual and corporate customers in the mid-to-high-end automotive segment. In recent developments, the Group pursues diversification through investments in high-tech ventures, including a chip production business via a joint venture with Reabon Technology Co., Limited for lithium niobate crystals and thin films through Guangzhou Jinghong New Materials Co., Ltd., with HK$74.94 million allocated from 2025 placing proceeds for phase-one and phase-two production lines targeting 50,000 wafers annually initially; an anion exchange membrane (AEM) business involving potential reinvestment in AIMI Investments Limited after providing HK$17 million debt financing in January 2025 (with HK$12 million repaid), planning up to HK$70 million for AEM electrolyzer production; and a hair growth products business securing exclusive global rights to the Groland trademark and licenses for peptides XTP-016 and XTP-118 in May 2025, with HK$95.59 million allocated for production and distribution. Further, the Group completed a subscription of new shares raising HK$11.34 million in June 2024 and a rights issue targeting HK$172.8 million in late 2024, alongside board changes such as the appointment of Zhang Xiaoyang as Co-Chairman in December 2024 and Jin Zhehui as Executive Director in July 2024.